January 27, 2009- For the second straight year, GE Healthcare has earned top honors for Overall OEM Service for cardiovascular X-ray systems in the 2008 IMV ServiceTrak Imaging X-Ray Cardiovascular Systems report.

IMV ServiceTrak reports present a broad, independent analysis of service trends in the imaging industry. The 2008 cardiovascular X-ray survey included 694 responses across four major OEMs. GE received the highest ranking in 17 of the 34 service attributes and improvements in 26 categories.

January 27, 2009 - Lantheus Medical Imaging Inc. said today new data from a prospective, non-randomized, multi-national study shows gated single-photon emission computed tomographic (SPECT) myocardial perfusion imaging (MPI) with Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection) had a 96 percent negative predictive value for diagnosing extensive coronary artery disease in patients hospitalized with their first episode of heart failure.

These study findings were published in the January/February 2009 issue of The Journal of Nuclear Cardiology.

January 27, 2009 - The FDA notified healthcare professionals Monday that the makers of Plavix, Bristol-Myers Squibb/Sanofi Pharmaceuticals, agreed to work with FDA to conduct studies to get a better understanding of the effects of genetic factors and other drugs (especially the proton pump inhibitors - PPIs) on the effectiveness of clopidogrel.

January 27, 2009 - Medtronic Inc. today reported the first enrollment in VITALITY, the company’s post-market clinical study of its Talent Abdominal Stent Graft for the endovascular repair of abdominal aortic aneurysms.

January 27, 2009 - Thanks to the CardioWest temporary Total Artificial Heart and portable driver, recipient Mr. Potiron was able to leave University Hospital of Nantes for the first time in more than a year to celebrate Christmas at home.

January 27, 2009 - Babcock & Wilcox Technical Services Group Inc. recently signed an agreement with Covidien to develop technology for the manufacture of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), the most widely used radioisotope for molecular imaging and nuclear medicine procedures.

January 27, 2009 - Mardil Inc., a cardiac device company with novel technology for treating mitral valve regurgitation, has successfully advanced its device to first-in-human testing, the company announced yesterday.

January 27, 2009 - According to research findings from Interventional Cardiologist Paul A. Gurbel, M.D., director of the Sinai Center for Thrombosis Research based at Sinai Hospital of Baltimore, platelet aggregation or "stickiness" may be the single most important risk factor in patients treated with coronary stents.

January 26, 2009 - CeloNova BioSciences Inc. recently received FDA 510(k) marketing clearance for Embozene Color-Advanced Microspheres, which are indicated for the treatment of hypervascularized tumors (tumors with a large number of blood vessels in many locations) and arteriovenous malformations (defects in the circulatory system).

January 26, 2009 - Cardiac Dimensions Inc. today said it achieved the implant target for the TITAN (TIghten The Annulus Now) safety study during the fourth quarter of 2008, which uses the CARILLON Mitral Contour System for percutaneous treatment of functional mitral regurgitation (FMR).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now